BAIT
Live / Applied — Extension of time to oppose received (as of 14 Sept 2026)
What this means for you
Not registered yet, but its 14 Apr 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99762898
- Mark type
- Stylized text
- Filed
- 14 Apr 2026
- Published for opposition
- 18 Aug 2026
- Attorney of record
- Makiko Coffland
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of infectious diseases, viral diseases, respiratory diseases, oncological diseases, and cancer; Antibodies for medical purposes; Therapeutic antibodies for human use for the treatment of infectious diseases, viral diseases, respiratory diseases, oncological diseases, and cancer; Biological preparations for the prevention and treatment of cancer, oncological diseases, infectious disease, respiratory diseases, and viral infections
- Class 042 — Scientific and technological services: Medical research in the field of immunotherapy; Providing medical and scientific research information; Research and development of antibodies
Owner
- Eradivir, Inc., West Lafayette, IN, US
- Eradivir, Inc., West Lafayette, IN, US
Prosecution history
- 14 Sept 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 18 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Aug 2026 — PUBLISHED FOR OPPOSITION
- 12 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jul 2026 — ASSIGNED TO EXAMINER
- 14 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 14 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Apr 2026 — NEW APPLICATION ENTERED